Page 13 - 《中国药房》2022年24期
P. 13

tXxgk.htm?id=347e8d20a6d442ddab626312378311b4.      antibiotic groups:an analysis of sales data from 70 middle-
          [14]  国家卫生健康委员会.《抗菌药物临床应用管理办法》有                         income  and  high-income  countries[J]. Lancet  Infect  Dis,
              关问题答疑[EB/OL].(2012-05-09)[2021-07-17]. http://      2019,19(1):67-75.
              www.nhc.gov.cn/wjw/zcjd/201304/43c21ad2846d4cd5878  [25]  SULIS  G,ADAM  P,NAFADE  V,et  al. Antibiotic  pre‐
              5310fc1fc775a.shtml.                                scription  practices  in  primary  care  in  low-  and  middle-
          [15]  WUSHOUER  H,ZHOU  Y,ZHANG  X,et  al.  Secular     income  countries:a  systematic  review  and  meta-analysis
              trend analysis of antibiotic utilisation in China’s hospitals   [J]. PLoS Med,2020,17(6):e1003139.
              2011-2018,a  retrospective  analysis  of  procurement  data  [26]  PAUWELS I,VERSPORTEN A,DRAPIER N,et al. Hos‐
              [J]. Antimicrob Resist Infect Control,2020,9(1):53.  pital  antibiotic  prescribing  patterns  in  adult  patients  ac‐
          [16]  World Health Organization. The 2021 WHO AWaRe classi-   cording to the WHO Access,Watch and Reserve classifi‐
              fication of antibiotics for evaluation and monitoring of use  cation (AWaRe):results  from  a  worldwide  point  preva‐
              [EB/OL].  [2022-06-02].  https://apps. who. int/iris/rest/bit‐  lence survey in 69 countries[J]. J Antimicrob Chemother,
              streams/1374989/retrieve.                           2021,76(6):1614-1624.
          [17]  World Health Organization. Critically important antimicro‐  [27]  WUSHOUER H,TIAN Y,GUAN X D,et al. Trends and
              bials  for  human  medicine:6th  revision  2018[EB/OL].  patterns of antibiotic consumption in China’s tertiary ho-
              (2019-03-20)[2022-06-02]. https://apps.who.int/iris/rest/  spitals:based on a 5 year surveillance with sales records,
              bitstreams/1217095/retrieve.                        2011-2015[J]. PLoS One,2017,12(12):e0190314.
          [18]  World Health Organization. Prioritization of pathogens to   [28]  PALWE  S,VEERARAGHAVAN  B,PERIASAMY  H,et
              guide  discovery,research  and  development  of  new  anti-  al.  Unorthodox  parenteral  β -lactam  and  β -lactamase
              biotics  for  drug-resistant  bacterial  infections,including        inhibitor combinations:flouting antimicrobial stewardship
              tuberculosis[EB/OL].(2017-09-04)[2022-06-02].  https://  and  compromising  patient  care[J].  Antimicrob  Agents
              apps.who.int/iris/rest/bitstreams/1214671/retrieve.  Chemother,2020,64(5):e00168-e00120.
          [19]  World Health Organization. WHO antibiotic categorization  [29]  BUDD E,CRAMP E,SHARLAND M,et al. Adaptation
              [EB/OL].  [2022-06-02]. https://aware. essentialmeds. org/  of the WHO Essential Medicines List for national antibio-
              groups.                                             tic  stewardship  policy  in  England:being  AWaRe[J].  J
          [20]  World  Health  Organization.  The  selection  and  use  of        Antimicrob Chemother,2019,74(11):3384-3389.
              essential medicines[EB/OL].(2017-01-30)[2022-06-02].  [30]  国家卫生健康委员会. 中国抗微生物药物管理和耐药现
              https://apps.who.int/iris/rest/bitstreams/1091561/retrieve.  状报告:2021[M]. 北京:中国协和医科大学出版社,
          [21]  HSIA Y,LEE  B  R,VERSPORTEN A,et  al.  Use  of  the   2021:28.
              WHO Access,Watch,and Reserve classification to define   [31]  耐甲氧西林金黄色葡萄球菌感染防治专家委员会. 耐甲
              patterns of hospital antibiotic use (AWaRe):an analysis   氧西林金黄色葡萄球菌感染防治专家共识[J]. 中华实验
              of  paediatric  survey  data  from  56  countries[J].  Lancet   和临床感染病杂志(电子版),2010,4(2):215-223(2010-
              Glob Health,2019,7(7):e861-e871.                    05-15)[2022-06-02].  https://kns. cnki. net/kcms/detail/de‐
          [22]  KLEIN E Y,MILKOWSKA-SHIBATA M,TSENG K K,          tail. aspx? dbcode=CJFD&dbname=CJFD2010&filename=
              et  al.  Assessment  of  WHO  antibiotic  consumption  and      ZSGR201002021&uniplatform=NZKPT&v=v4wVzkq7zco5
              access  targets  in  76  countries,2000-15:an  analysis  of   3pKw5nYnez5ajR4eGeFnOkO8AL0qw_xD3raZekOfxd0KBY-
              pharmaceutical sales data[J]. Lancet Infect Dis,2021,21  5mdqon.
              (1):107-115.                                   [32]  European  Centre  for  Disease  Prevention  and  Control.
          [23]  WANG C N,HUTTNER B D,MAGRINI N,et al. Pediatric   WHO and ECDC report:antimicrobial resistance remains
              antibiotic  prescribing  in  China  according  to  the  2019   a health threat in Europe[EB/OL].(2022-01-26)[2022-06-
              World  Health  Organization  access,watch,and  reserve   02].  https://www. ecdc. europa. eu/en/news-events/who-and-
              (AWaRe)antibiotic  categories[J].  J  Pediatr,2020,220:  ecdc-report-antimicrobial-resistance-remains-health-threat-
              125-131.e5.                                         europe.
          [24]  HSIA Y,SHARLAND M,JACKSON C,et al. Consump‐                 (收稿日期:2022-08-22  修回日期:2022-11-16)
              tion of oral antibiotic formulations for young children ac‐                         (编辑:孙 冰)
              cording  to  the  WHO Access,Watch,Reserve (AWaRe)




          中国药房  2022年第33卷第24期                                              China Pharmacy  2022 Vol. 33  No. 24    · 2951 ·
   8   9   10   11   12   13   14   15   16   17   18